Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults

This study has been terminated.
(Occurrence of unacceptable adverse events.)
Oswaldo Cruz Foundation
George Washington University
London School of Hygiene and Tropical Medicine
Information provided by (Responsible Party):
Albert B. Sabin Vaccine Institute Identifier:
First received: May 14, 2007
Last updated: July 6, 2012
Last verified: July 2012